Sanders Morris Harris LLC Macrogenics Inc Transaction History

Sanders Morris Harris LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 13, 2021	SELL	$20.49 - $35.63 $52,659 - $91,569	-2,570 Reduced 12.29%	18,345 $522,000
Q3 2020 Oct 16, 2020	BUY	$24.69 - $31.6 $516,391 - $660,914	20,915 New	20,915 $540,000
Q2 2020 Jul 09, 2020	SELL	$5.2 - $29.12 $123,994 - $694,366	-23,845 Closed	0 $0
Q1 2020 Apr 09, 2020	BUY	$4.28 - $12.11 $102,056 - $288,762	23,845 New	23,845 $125,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

Stay updated on Sanders Morris Harris LLC with notifications on news.